KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
11.90
-0.29 (-2.42%)
At close: May 9, 2025, 4:00 PM
12.49
+0.60 (5.00%)
After-hours: May 9, 2025, 5:39 PM EDT

KalVista Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 6 professional analysts, the 12-month price target for KalVista Pharmaceuticals stock ranges from a low of $19 to a high of $30. The average price target of $24.83 forecasts a 108.74% increase in the stock price over the next year.

Price Target: $24.83 (+108.74%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $19 $24.83 $28 $30
Change +59.73% +108.74% +135.39% +152.21%
* Price targets were last updated on Apr 8, 2025.

Analyst Ratings

The average analyst rating for KalVista Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Dec '24Jan '25Feb '25Mar '25Apr '25May '25
Strong Buy 455555
Buy 233333
Hold 000000
Sell 000000
Strong Sell 000000
Total 688888

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Needham
Needham
Strong Buy
Reiterates
$28
Strong Buy Reiterates $28 +135.39% Apr 8, 2025
Needham
Needham
Strong Buy
Reiterates
$28
Strong Buy Reiterates $28 +135.39% Mar 26, 2025
Citizens Capital Markets
Citizens Capital Markets
Buy
Reiterates
$19
Buy Reiterates $19 +59.73% Mar 26, 2025
Jones Trading
Jones Trading
Strong Buy
Maintains
$30
Strong Buy Maintains $30 +152.21% Mar 26, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$20
Strong Buy Reiterates $20 +68.14% Mar 14, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
31.44M
EPS This Year
-3.60
from -3.44
EPS Next Year
-3.07
from -3.60
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Apr 30, 2020 Apr 30, 2021 Apr 30, 2022 Apr 30, 2023 Apr 30, 2024 Apr 30, 2025 Apr 30, 2026 Apr 30, 2027
Revenue
12.69M-----31.44M112.20M
Revenue Growth
-21.31%------256.90%
EPS
-1.64-2.42-3.36-3.33-3.44-3.60-3.07-1.91
EPS Growth
--------
Forward PE
--------
No. Analysts
-----12129
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027202820292030
High n/a 58.2M 148.2M
Avg n/a 31.4M 112.2M
Low n/a 15.4M 43.1M

Revenue Growth

Revenue Growth 202520262027202820292030
High - -
371.4%
Avg - -
256.9%
Low - -
37.1%

EPS Forecast

EPS 202520262027202820292030
High -3.51 -2.53 -1.04
Avg -3.60 -3.07 -1.91
Low -3.59 -3.68 -2.69

EPS Growth

EPS Growth 202520262027202820292030
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.